Altimmune, Inc. (ALT) vs CorMedix Inc. (CRMD)

A side-by-side comparison of Altimmune, Inc. and CorMedix Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ALT vs CRMD

growth of $100 · dividends reinvested · last 9y
ALT -98.0% (-35.2%/yr)CRMD +245.7% (+14.8%/yr)CRMD compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $1002019202120232025$2$346
ALT CRMD

ALT vs CRMD: by the numbers

  • •CRMD is the larger company ($570M vs $519M market cap).
  • •CRMD is profitable (40.49% net margin) while ALT runs a net loss (-296000.00%).
  • •CRMD grew revenue faster over the past five years (352.03% vs -65.38% CAGR).

Metrics side by side

Valuation

MetricALTCRMD
P/E ratioN/A3.41
Forward P/EN/A14.67
P/S ratio16749.861.23
P/B ratio1.091.24
EV / EBITDAN/A1.82
FCF yieldN/A43.94%

Profitability

MetricALTCRMD
Gross margin100.00%82.78%
Operating margin-230460.98%46.95%
Net margin-296000.00%40.49%
ROE-19.35%40.62%
ROIC-19.47%27.87%

Growth (annualized)

MetricALTCRMD
Revenue CAGR (5Y)-65.38%352.03%
Total return CAGR (5Y)-25.30%9.70%

Frequently asked

Which has grown faster, ALT or CRMD?
Over the past five years, CRMD grew revenue faster — ALT at a -65.38% CAGR versus CRMD at 352.03%.
Is ALT or CRMD more profitable?
CRMD runs the higher net margin — ALT at -296000.00% versus CRMD at 40.49%.
How have ALT and CRMD total returns compared?
Over the past 5 years, ALT delivered -25.30% and CRMD delivered 9.70% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.